Ignite Creation Date:
2024-05-06 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03668613
Status:
COMPLETED
Last Update Posted:
2024-03-20
First Post:
2018-08-23
Brief Title:
Study to Assess the Long-term Safety Tolerability Efficacy of Secukinumab in Pediatric Patients of Age 6 to 18 Years With Moderate to Severe Plaque Psoriasis
Sponsor:
Organization:
Novartis